Dopamine receptor-modulated [35S]GTPγS binding in striatum of 6- hydroxydopamine-lesioned rats

Brain Research

Volumn 841, Issue 1-2, 1999, Pages 135-142

  Geurts, Muriel ^a   Hermans, Emmanuel ^a   Cumps, Jean ^a   Maloteaux, Jean Marie ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

6 Hydroxydopamine; 35S GTP S; Receptor G protein coupling; Striatum; Supersensitivity

Indexed keywords

DOPAMINE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; NEUROTOXIN; OXIDOPAMINE;

ANIMAL TISSUE; ARTICLE; CORPUS STRIATUM; DENERVATION; MALE; MICROINJECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR SENSITIVITY; RECEPTOR UPREGULATION; SUPERSENSITIVITY;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; APOMORPHINE; BROMOCRIPTINE; CELL MEMBRANE; CORPUS STRIATUM; DOMPERIDONE; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); LIGANDS; MALE; OXIDOPAMINE; PIPERAZINES; QUINPIROLE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SULFUR RADIOISOTOPES; TRITIUM;

EID: 0033546934     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01812-0     Document Type: Article

References (36)

1. 2 mRNA and receptor levels in the striatum and nucleus accumbens of the rat. Brain Res. Mol. Brain Res. 11:1991;161-166.
2. 1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro. Eur. J. Pharmacol. 213:1992;259-267.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
4. Butkerait P., Friedman E. Repeated reserpine increases striatal dopamine receptor and guanine nucleotide binding protein mRNA. J. Neurochem. 60:1993;566-571.
5. Butkerait P., Wang H.-Y., Friedman E. Increases in guanine nucleotide binding to striatal G proteins is associated with dopamine receptor supersensitivity. J. Pharmacol. Exp. Ther. 271:1994;422-428.
6. Cole D.G., Kobierski L.A., Konradi C., Hyman S.E. 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons. Proc. Natl. Acad. Sci. U.S.A. 91:1994;9631-9635.
7. s-protein coupling. Eur. J. Pharmacol. 207:1991;271-274.
8. Creese I., Burt D.R., Snyder S.H. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. Science. 197:1977;596-598.
9. Enz A., Goldstein M., Meller E. Dopamine agonist-induced elevation of striatal acetylcholine: relationship between receptor occupancy and response in normal and denervated rat striatum. Mol. Pharmacol. 37:1990;560-565.
10. 35S ]GTPγS binding in striatum of 6-hydroxydopamine-lesioned rats Naunyn-Schmiedeberg's Arch. Pharmacol. 358:1998;R102. Suppl. 1.
11. 35S ]GTPγS binding, Life Sci., in press.
12. 2 dopamine receptors and dopamine uptake sites in the 6-hydroxydopamine lesioned rat - an autoradiographic study. Brain Res. 640:1994;185-194.
13. 1 receptor with adenylyl cyclase. J. Neurosci. 13:1993;2237-2248.
14. 1 receptor stimulation. J. Neurosci. 10:1990;2318-2329.
15. Koelle M.R. A new family of G-protein regulators - the RGS proteins. Curr. Opin. Cell Biol. 9:1997;143-147.
16. 2 receptor density: autoradiographic evidence against the dual mechanism hypothesis. Neuroscience. 41:1991;473-481.
17. 2 synergism are unrelated to changes in striatal receptor density. Synapse. 12:1992;14-26.
18. Lazareno S., Farries T., Birdsall N.J. Pharmacological characterization of guanine nucleotide exchange reactions in membranes from CHO cells stably transfected with human muscarinic receptors m1-m4. Life Sci. 52:1993;449-456.
19. 35S ]thio)triphosphate binding Mol. Pharmacol. 44:1993;115-123.
20. Marcotte E.R., Sullivan R.M., Mishra R.K. Striatal G-proteins: effects of unilateral 6-hydroxydopamine lesions. Neurosci. Lett. 169:1994;195-198.
21. E.R. Marcotte, R.K. Mishra, G proteins and animal models of Parkinson's disease, in: R.K. Mishra, G.B. Baker, A.A. Boulton (Eds.), Neuromethods: G Protein Methods and Protocols, Role of G proteins in Psychiatric and Neurological Disorders, Vol. 31, Humana Press, Totowa, 1997, pp. 139-161.
22. Mishra R.K., Gardner E.L., Katzman R., Makman M.H. Enhancement of dopamine-stimulated adenylate cyclase activity in rat caudate after lesions in the substantia nigra: evidence for denervation supersensitivity. Proc. Natl. Acad. Sci. U.S.A. 71:1974;3883-3887.
23. Mishra R.K., Marshall A.M., Varmuza S.L. Supersensitivity in rat caudate nucleus: effects of 6-hydroxydopamine on the time course of dopamine receptor and cyclic AMP changes. Brain Res. 200:1980;47-57.
24. Odagaki Y., Nishi N., Koyama T. Receptor-mediated and receptor-independent activation of G-proteins in rat brain membranes. Life Sci. 62:1998;1537-1541.
25. G. Paxinos, C. Watson (Eds.), The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego, 1986.
26. Penit-Soria J., Durand C., Besson M.J., Herve D. Levels of stimulatory G protein are increased in the rat striatum after neonatal lesion of dopamine neurons. NeuroReport. 8:1997;829-833.
27. 35S ]GTPγS) binding in rat striatal membranes Biochem. Pharmacol. 57:1999;155-162.
28. 2 dopamine receptors: involvement of G proteins in the development of receptor supersensitivity. J. Neurochem. 59:1992;1667-1674.
29. D.R. Sibley, K.A. Neve, Regulation of dopamine receptor function and expression, in: K.A. Neve, R.L. Neve (Eds.), The Dopamine Receptors, Humana Press, Totowa, 1997, pp. 383-424.
30. Staunton D.A., Wolfe B.B., Groves P.M., Molinoff P.B. Dopamine receptor changes following destruction of the nigrostriatal pathway: lack of a relationship to rotational behavior. Brain Res. 211:1981;315-327.
31. Thomas K.L., Rose S., Jenner P., Marsden C.D. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation. Biochem. Pharmacol. 44:1992;73-82.
32. Ueda H., Sato K., Okumura F., Inoue A., Nakata Y., Ozaki N., Yue J.L., Misu Y. Supersensitization of neurochemical responses by L-DOPA and dopamine receptor agonists in the striatum of experimental Parkinson's disease model rats. Biomed. Pharmacother. 49:1995;169-177.
33. Ungerstedt U. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur. J. Pharmacol. 5:1968;107-110.
34. Ungerstedt U., Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 24:1970;485-493.
35. s proteins. J. Pharmacol. Exp. Ther. 273:1995;492-498.
36. Yamane H.K., Fung B.K.-K. Covalent modifications of G-proteins. Annu. Rev. Pharmacol. Toxicol. 32:1993;201-241.